Literature DB >> 18081162

Clinical significance of RLS.

Wayne A Hening1, Richard P Allen, K Ray Chaudhuri, Magdolna Hornyak, Hochang B Lee, John Winkelman, Robert Yoakum.   

Abstract

While the restless legs syndrome (RLS) may have been known in antiquity, it has only recently come to medical attention. Individuals with RLS fall along a spectrum from mild, infrequent symptoms to those with severe daily life-impairing discomforts and sleep disruption. These problems can cause impaired mood, daytime fatigue, cognitive difficulties, and inability to participate in a variety of quiet activities. This leads to a general reduction in quality of life similar to other significant psychiatric and medical disorders. Recent studies suggest that RLS may be a risk factor for developing both psychiatric disorders (such as major depression and anxiety) and somatic diseases (such as hypertension and cardiovascular disease). In dialysis patients, RLS has been found to be a risk factor for mortality. Therefore, those with RLS who have clinically significant symptoms suffer increased morbidity and are at risk for impaired long-term medical outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 18081162     DOI: 10.1002/mds.21665

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

Review 2.  Prevalence of restless legs syndrome in North American and Western European populations: a systematic review.

Authors:  Kim E Innes; Terry Kit Selfe; Parul Agarwal
Journal:  Sleep Med       Date:  2011-07-12       Impact factor: 3.492

3.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Prospective study of restless legs syndrome and mortality among men.

Authors:  Yanping Li; Wei Wang; John W Winkelman; Atul Malhotra; Jing Ma; Xiang Gao
Journal:  Neurology       Date:  2013-06-12       Impact factor: 9.910

5.  Restless legs syndrome in an appalachian primary care population: prevalence, demographic and lifestyle correlates, and burden.

Authors:  Kim E Innes; Kathryn L Flack; Terry Kit Selfe; Sahiti Kandati; Parul Agarwal
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

6.  Quality measures for the care of adult patients with restless legs syndrome.

Authors:  Lynn Marie Trotti; Cathy A Goldstein; Christopher G Harrod; Brian B Koo; Denise Sharon; Rochelle Zak; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

7.  Prospective study of restless legs syndrome and risk of depression in women.

Authors:  Yanping Li; Fariba Mirzaei; Eilis J O'Reilly; John Winkelman; Atul Malhotra; Olivia Ifeoma Okereke; Alberto Ascherio; Xiang Gao
Journal:  Am J Epidemiol       Date:  2012-07-17       Impact factor: 4.897

8.  Autonomic complaints in patients with restless legs syndrome.

Authors:  Natalya Shneyder; Charles H Adler; Joseph G Hentz; Holly Shill; John N Caviness; Marwan N Sabbagh; Thomas G Beach; Erika Driver-Dunckley
Journal:  Sleep Med       Date:  2013-09-21       Impact factor: 3.492

9.  [Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study].

Authors:  Sandra Nelles; Juliane Köberlein; Christine Grimm; David Pittrow; Wilhelm Kirch; Reinhard Rychlik
Journal:  Med Klin (Munich)       Date:  2009-05-16

10.  Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial.

Authors:  Kim E Innes; Terry Kit Selfe; Caitlin Montgomery; Nicole Hollingshead; Zenzi Huysmans; Roshini Srinivasan; Sijin Wen; Madeleine J Hausmann; Karen Sherman; Maryanna Klatt
Journal:  J Clin Sleep Med       Date:  2020-01-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.